Patents Assigned to Technion Research & Development
  • Publication number: 20100166833
    Abstract: Articles of manufacturing, methods, devices and compositions for preventing or reducing tobacco-associated damage in a subject, and which utilize a metal ion chelating agent, a copper chelating agent, a penicillamine and/or a structural analog of penicillamine, with and without an additional antioxidant, are disclosed.
    Type: Application
    Filed: October 29, 2009
    Publication date: July 1, 2010
    Applicant: Technion Research & Development Foundation Ltd.
    Inventors: Moshe Gavish, Rafael M. Nagler
  • Publication number: 20100165195
    Abstract: A method for multiplexing measurements of related values using predetermined numbers of sources having intensities and subject to noise, and at least one sensor subject to saturation, said multiplexing comprising measuring each of said related values under a plurality of different combinations of said sources, the method comprises: generating a first set of multiplexing combinations; constraining said first set with respect to said saturation; modifying said first set with respect to said noise until an optimum is found between respective intensities and noise, and measuring said variables by multiplexing said sources according to said modified set.
    Type: Application
    Filed: March 13, 2008
    Publication date: July 1, 2010
    Applicant: Technion Research & Development Foundation Ltd.
    Inventors: Netanel Ratner, Yoav Yosef Schechner
  • Publication number: 20100158927
    Abstract: A method of diagnosing melanoma and antibodies capable of same are disclosed. The method comprises contacting a cell of the subject with an antibody comprising an antigen recognition domain capable of binding to an MHC-I molecule being complexed with a tyrosinase peptide, wherein the antibody does not bind the MHC-I in the absence of the complexed peptide, and wherein the antibody does not bind the peptide in an absence of the MHC, under conditions which allow immunocomplex formation, wherein a presence of the immunocomplex or level thereof is indicative of the melanoma. Methods for treating melanoma and antibodies capable of same are also disclosed. Pharmaceutical compositions comprising antibodies are also disclosed.
    Type: Application
    Filed: March 27, 2008
    Publication date: June 24, 2010
    Applicant: Technion Research & Development Foundation Ltd.
    Inventors: Yoram Reiter, Cyril Cohen, Eynav Klechevsky, Yael Michaeli, Maya Haus-Cohen, Galit Denkberg
  • Publication number: 20100143964
    Abstract: Methods for concentrating microorganisms in a liquid sample or depleting microorganisms therefrom, utilizing polymeric compounds having affinity to microbial cells that are composed of a plurality of positively charged amino acid residues and two or more hydrophobic moieties are disclosed. Also disclosed are devices for concentrating and methods for detection and identification microorganisms in a liquid sample.
    Type: Application
    Filed: December 13, 2007
    Publication date: June 10, 2010
    Applicant: Technion Research & Development Foundation Ltd.
    Inventors: Amram Mor, Shahar Rotem, Yechezkel Kashi, Nili Raz
  • Publication number: 20100137351
    Abstract: The present invention provides IA derivative compounds of the formula: where the variables are described herein.
    Type: Application
    Filed: September 10, 2009
    Publication date: June 3, 2010
    Applicant: Technion Research & Development Foundation Ltd.
    Inventors: Yehuda G. Assaraf, Eran E. Bram, Yamit Bney-Moshe, Andrzej M. Skladanowski
  • Publication number: 20100135967
    Abstract: A method of generating cultured chondrocytes/endochondral bone cells is provided. The method comprising isolating chondrocytes from mandibular condyle tissue, and culturing the isolated chondrocytes. A method of isolating chondrocytes from mandibular condyle tissue is further provided. The method comprises isolating mandibular condyle tissue from a mammal and treating the mandibular condyle tissue so as to selectively remove fibroblast-like cells and/or myocytes therefrom, the modified mandibular condyle tissue including chondrocytes, and selectively collecting the chondrocytes from the modified mandibular condyle tissue.
    Type: Application
    Filed: December 7, 2009
    Publication date: June 3, 2010
    Applicant: Technion Research & Development Foundation Ltd.
    Inventor: Gila Maor
  • Publication number: 20100129907
    Abstract: A cell culture comprising human foreskin cells, the human foreskin cells being capable of maintaining stem cells in an undifferentiated state when co-cultured therewith.
    Type: Application
    Filed: January 28, 2010
    Publication date: May 27, 2010
    Applicant: Technion Research & Development Foundation Ltd.
    Inventors: Michal AMIT, Joseph Itskovitz-Eldor
  • Patent number: 7718777
    Abstract: Disclosed are protein ligands comprising an immunoglobulin heavy chain variable (VH) domain and an immunoglobulin light chain variable (VL) domain, wherein the proteins bind a complex comprising an MHC and a peptide, do not substantially bind the MHC in the absence of the bound peptide, and do not substantially bind the peptide in the absence of the MHC, and the peptide is a peptide fragment of gp100, MUC1, TAX, or hTERT. Also disclosed are methods of using and identifying such ligands.
    Type: Grant
    Filed: October 18, 2006
    Date of Patent: May 18, 2010
    Assignee: Technion Research & Development Foundation Ltd.
    Inventors: Henricus Renerus Jacobus Mattheus Hoogenboom, Yoram Reiter
  • Patent number: 7716625
    Abstract: A complementary logic circuit contains a first logic input, a second logic input, a first dedicated logic terminal, a second dedicated logic terminal, a first logic block, and a second logic block. The first logic block consists of a network of p-type transistors for implementing a predetermined logic function. The p-type transistor network has an outer diffusion connection, a first network gate connection, and an inner diffusion connection. The outer diffusion connection of the p-type transistor network is connected to the first dedicated logic terminal, and the first network gate connection of the p-type transistor network is connected to the first logic input. The second logic block consists of a network of n-type transistors which implements a logic function complementary to the logic function implemented by the first logic block. The n-type transistor network has an outer diffusion connection, a first network gate connection, and an inner diffusion connection.
    Type: Grant
    Filed: July 13, 2007
    Date of Patent: May 11, 2010
    Assignee: Technion Research & Development Foundation Ltd.
    Inventors: Arkadiy Morgenshtein, Alexander Fish, Israel A. Wagner
  • Publication number: 20100111957
    Abstract: Anti CMV antibodies are provided. Thus an antibody of the present invention comprises an antigen recognition domain capable of binding an MHC molecule being complexed with a cytomegalovirus (CMV) pp65 or pp64 peptide, wherein the antibody does not bind said MHC molecule in an absence of said complexed peptide, and wherein the antibody does not bind said peptide in an absence of said MHC molecule. Also provided are methods of using the antibodies.
    Type: Application
    Filed: March 27, 2008
    Publication date: May 6, 2010
    Applicant: Technion Research & Development Foundation Ltd.
    Inventors: Oryan Makler, Yoram Reiter
  • Publication number: 20100107596
    Abstract: A low power hall thruster is provided that is effective for micro-spacecrafts and nano-spacecrafts as well as mini-spacecrafts. The hall thruster comprises a co-axial acceleration channel capable of being applied with predominantly-radial magnetic field and a co-axial anode within a cavity capable of being applied with substantially longitudinal magnetic field. A cathode-compensator is placed beyond the acceleration channel and magnetic system is provided capable of generating the radial magnetic field within the co-axial acceleration channel and the longitudinal magnetic field within the co-axial anode. An electrically isolated gas distributor is also provided.
    Type: Application
    Filed: November 11, 2007
    Publication date: May 6, 2010
    Applicant: Technion Research & Development Foundation Ltd.
    Inventors: Alexander Kapulkin, Mauricio Moshe Guelman, Vladimir Balabanov, Binyamin Rubin
  • Publication number: 20100108086
    Abstract: Articles of manufacturing for preventing or reducing tobacco smoke- and smokeless-tobacco associated injury in the aerodigestive tract of a subject are disclosed, which comprise at least one agent capable of reducing or preventing tobacco associated loss of peroxidase activity in said aerodigestive tract, said at least one agent being selected from the group consisting of a cyanide chelator and an iron chelator.
    Type: Application
    Filed: January 22, 2008
    Publication date: May 6, 2010
    Applicant: Technion Research & Development Foundation Ltd
    Inventors: Abraham Z. Reznick, Rafael M. Nagler
  • Patent number: 7699778
    Abstract: An ultrasound cardiac stimulation system comprising: a spatially selective ultrasound source comprising at least one ultrasound transducer located outside the circulatory system; and a controller; where the controller generates an electrical response in the heart by directing the ultrasound source to transmit a high enough power level of ultrasound to one or more locations in the heart.
    Type: Grant
    Filed: February 19, 2003
    Date of Patent: April 20, 2010
    Assignee: Technion Research & Development Foundation Ltd.
    Inventor: Dan Adam
  • Publication number: 20100093840
    Abstract: A method and pharmaceutical compositions useful for inhibiting the growth of solid tumors are provided. Specifically, the method is effected by administering to a subject in need thereof an agent capable of upregulating the expression level and/or activity of at least a functional portion of Sef, wherein the functional portion being capable of inhibiting RTK-mediated cell proliferation. Also provided are methods and kits for diagnosing and staging of cancer by detecting the expression level of hSef in a tissue sample, wherein a decrease in hSef expression level is indicative of cancer.
    Type: Application
    Filed: December 7, 2009
    Publication date: April 15, 2010
    Applicant: Technion Research & Development Foundation Ltd.
    Inventor: Dina Ron
  • Publication number: 20100092433
    Abstract: An isolated composition of matter is provided comprising a heterogeneous population of cells seeded on a surface of a scaffold, wherein the heterogeneous population of cells comprises at least one pancreatic islet, endothelial cells and fibroblast cells. Methods of generating same and uses thereof are also provided.
    Type: Application
    Filed: March 12, 2008
    Publication date: April 15, 2010
    Applicant: Technion Research & Development Foundation Ltd.
    Inventors: Shulamit Levenberg, Keren Francis
  • Publication number: 20100080805
    Abstract: A composition-of-matter comprising an antibody or antibody fragment including an antigen-binding region capable of specifically binding an antigen-presenting portion of a complex composed of a human antigen-presenting molecule and an antigen derived from a pathogen is disclosed.
    Type: Application
    Filed: November 17, 2009
    Publication date: April 1, 2010
    Applicant: Technion Research & Development
    Inventors: Yoram Reiter, Cyril Cohen
  • Patent number: 7682787
    Abstract: The present invention uncovers that mutations in GALNT3 gene encoding UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase (GalNAc-T3) cause familial tumoral calcinosis (FTC). Methods and pharmaceutical compositions useful for treating disorders associated with abnormal phosphate metabolism are provided. Specifically, inducers of GalNAc-T3 can be used to treat hyperphosphatemia related disorders such as FTC, and on the other hand, inhibitors of GalNAc-T3 can be used to treat disorders associated with hypophosphatemia, such as hypophosphatemic rickets.
    Type: Grant
    Filed: June 18, 2004
    Date of Patent: March 23, 2010
    Assignee: Technion Research & Development Foundation Ltd.
    Inventors: Eli Sprecher, Reuven Bergman
  • Patent number: 7680757
    Abstract: A method for discovering association rules in a distributed database that includes a plurality of partitions associated with respective computing nodes includes generating a candidate association rule defining an association relationship between itemsets in the distributed database. At each node among at least a subset of the nodes, an asynchronous fully-distributed majority voting process is applied to assess a correctness of the candidate association rule.
    Type: Grant
    Filed: November 9, 2005
    Date of Patent: March 16, 2010
    Assignee: Technion Research & Development Foundation Ltd.
    Inventors: Ran Wolff, Assaf Schuster
  • Publication number: 20100062001
    Abstract: A recombinant isolated antibody and a pharmaceutical composition containing same, capable of specifically recognizing an MHC-peptide complex with an affinity in a nanomolar range and of inducing apoptosis in cancer or pathogen infected cells is provided. Also provided are method for treating and diagnosing cancer or pathogen infection in a subject using the recombinant isolated antibody of the present invention.
    Type: Application
    Filed: June 9, 2005
    Publication date: March 11, 2010
    Applicant: Technion Research & Development
    Inventors: Yoram Reiter, Eynav Klechevsky, Galit Denkberg
  • Publication number: 20100045778
    Abstract: A system and a method for acquiring an image of a particle flowing in a vessel, the system comprising a light source for generating an illuminating light, an imaging probe for laterally statically illuminating at least a portion of said vessel with the illuminating light, a detection unit for detecting emitted light from an illuminated portion of said particle, and a processor unit for reproducing an image of the illuminated portion of said particle from the emitted light.
    Type: Application
    Filed: August 17, 2009
    Publication date: February 25, 2010
    Applicant: Technion Research & Development Foundation Ltd.
    Inventor: Dvir Yelin